Iontronics focuses on the interactions between electrons and ions, playing essential roles in most processes across physics, chemistry and life science. Osmotic power source as an example of iontronics, could transform ion gradient into electrical energy, however, it generates low power, sensitive to humidity and can’t operate under freezing point. Herein, based on 2D nanofluidic graphene oxide material, we demonstrate an ultrathin (∼10 µm) osmotic power source with voltage of 1.5 V, volumetric specific energy density of 6 mWh cm−3 and power density of 28 mW cm−3, achieving the highest values so far. Coupled with triboelectric nanogenerator, it could form a self-charged conformable triboiontronic device. Furthermore, the 3D aerogel scales up areal power density up to 1.3 mW cm−2 purely from ion gradient based on nanoconfined enhancement from graphene oxide that can operate under −40 °C and overcome humidity limitations, enabling to power the future implantable electronics in human-machine interface.

The efficacy of cancer catalytic therapy is still hindered by the inefficient generation of reactive oxygen species (ROS). Herein, we report a self-driven electrical stimulation-promoted cancer catalytic therapy and chemotherapy by integrating a human-driven triboelectric nanogenerator (TENG) with an implantable and biodegradable nanofibrous patch. The gelatin/polycaprolactone nanofibrous patch incorporates doxorubicin (DOX) and graphitic carbon nitride (g-C3N4), in which the peroxidase (POD)-like activity of g-C3N4 to produce hydroxyl radical (•OH) can be distinctly enhanced by the self-driven electrical stimulation for 4.12-fold, and simultaneously DOX can be released to synergize the therapy, especially under a weakly acidic tumor microenvironment (TME) condition. The in vitro and in vivo experimental results on a mouse breast cancer model demonstrate superior tumor suppression outcome. The self-powered electrical stimulation-enhanced catalytic therapy and chemotherapy via multifunctional nanofibrous patches proposes a new complementary strategy for the catalytic therapy of solid tumors.